Topic - Rahul Gupta

Gupta said his office is requesting $11 million as part of its budget to develop a strategy to tackle the drug's spread.

An emerging threat: Drug mix of xylazine, fentanyl →

Dr. Rahul Gupta, the director of the Office of National Drug Control Policy, said the designation should lead to limits on imports of xylazine, the formal name for tranq, while raising awareness and speeding the development of treatments. 

'Tranq'-fentanyl combo labeled emerging threat by drug czar Rahul Gupta →